216 -5 (79) 2025 - Narzullayeva O.M. - THE IMPACT OF EXPERIMENTAL ULCERATIVE COLITIS ON LIVER FUNCTION AND ESTROGEN METABOLISM IN RATS: ASSOCIATION WITH ENDOMETRIAL HYPERPLASIA

THE IMPACT OF EXPERIMENTAL ULCERATIVE COLITIS ON LIVER FUNCTION AND ESTROGEN METABOLISM IN RATS: ASSOCIATION WITH ENDOMETRIAL HYPERPLASIA

Narzullayeva O.M. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

This article explores the effect of experimental ulcerative colitis (EUC) on liver function and estrogen metabolism in rats, as well as the relationship of these factors with endometrial hyperplasia. Ulcerative colitis, a chronic inflammatory disease of the intestine, can exert systemic effects on the body, including impairment of liver function and hormonal balance. In the course of the study, EUC was induced in rats. Morphological changes in liver tissue were assessed, and immunohistochemical (IHC) evaluation of hyperplastic endometrium was performed using the ER marker. The results demonstrated that EUC leads to significant impairments in hepatic function, which in turn affect circulating estrogen levels and its metabolism. Moreover, a strong correlation was observed between disrupted estrogen metabolism and the development of endometrial hyperplasia in EUC-induced rats. These findings indicate a potential mechanism through which intestinal inflammation may influence the reproductive system. The obtained results underscore the importance of investigating the interconnection between intestinal diseases and systemic hormonal alterations, which may have significant clinical implications for understanding disease pathophysiology and developing new therapeutic strategies

Keywords: Ulcerative colitis, liver, endometrial hyperplasia, Wistar rats, estrogen, ER marker, IHC

First page

1064

Last page

1069

For citation:Narzullayeva O.M. - THE IMPACT OF EXPERIMENTAL ULCERATIVE COLITIS ON LIVER FUNCTION AND ESTROGEN METABOLISM IN RATS: ASSOCIATION WITH ENDOMETRIAL HYPERPLASIA//New Day in Medicine 5(79)2025 1064-1069 https://newdayworldmedicine.com/en/new_day_medicine/5-79-2025

List of References

1. Arem H., Irwin M.L. Obesity and endometrial cancer survival: a systematic review // Int J Obes (Lond). - 2013. -Vol. 37 (5). - P. 634-9.
2. SGO Clinical Practice Endometrial Cancer Working Group Endometrial cancer: a review and current management strategies: part II // Gynecol Oncol. - 2014. - Vol. 134 (2). - P. 393-402.
3. Cramer D.W. The epidemiology of endometrial and ovarian cancer // Hematol Oncol Clin North Am. - 2012. - Vol. 26 (1). - P. 1-12
4. Arora V., Quinn M.A. Endometrial cancer // Best Pract Res Clin Obstet Gynaecol. - 2012. - Vol. 26 (3). - P. 311-24.
5. Win A.K., Reece J.C., Ryan S. Family history and risk of endometrial cancer: a systematic review and meta-analysis // Obstet Gynecol. - 2015. - Vol. 125 (1). - P. 89-98.
6. Binder P.S., Mutch D.G. Update on prognostic markers for endometrial cancer // Womens Health (Lond Engl). -2014. - Vol. 10 (3). - P. 277-88.
7. Costales A.B., Schmeler K.M., Broaddus R. Clinically significant endometrial cancer risk following a diagnosis of complex atypical hyperplasia // Gynecol Oncol. - 2014. - Vol. 135 (3). - P. 451-4.
8. Gol K., Saracoglu F., Ekici A. Endometrial patterns and endocrinologic characteristics of asymptomatic menopausal women // Gynecol Endocrinol. - 2001. - Vol. 15. - P. 63-67.
9. Park J.C., Lim S.Y., Jang T.K. Endometrial histology and predictable clinical factors for endometrial disease in women with polycystic ovary syndrome // Clin Exp Reprod Med. - 2011. - Vol. 38. - P. 42-46.
10. Setiawan V.W., Yang H.P., Pike M.C. Type I and II endometrial cancers: have they different risk factors? // J Clin Oncol. - 2013. - Vol. 31 (20). - P. 2607-18.

    file

    download